This search function provides links to outputs produced by NIHR Innovation Observatory. These are briefing notes or reports on new or repurposed technologies. This search will not return all technologies currently in development as these outputs are produced as required for our stakeholders.

Innovation Observatory > Reports > Drugs > Galcanezumab for prevention of chronic cluster headache

< Back

Galcanezumab for prevention of chronic cluster headache


Neurology and Neurosurgery

March 2017

Galcanezumab is a drug for chronic cluster headaches, which are severe headaches on one side of the head that require constant pain relief. Most attacks occur during sleep, with recurring attacks lasting a year or more. Galcanezumab is taken once a month, blocking a protein which is involved in this type of headache.

Innovation Observatory Voice 0

Leave a Reply

Your email address will not be published. Required fields are marked *

Post Comment

PDF Report


Connect to the Innovation Observatory


Load More Related Posts

Get Alerts